Doctors and researchers are raising fresh concerns after new data revealed a sharp and sustained rise in alcohol use in cancer patients requiring unplanned hospital care across the United States. The findings, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, paint a troubling picture of how harmful drinking intersects with some of the most vulnerable patients in the healthcare system.

Alcohol Use in Cancer Patients: What the Numbers Reveal

Between 2016 and 2021, more than 12 million adults with cancer had unplanned hospital admissions. Of those, 15,205 were directly linked to alcohol. That represents an average rise of roughly 185 cases per year, with total admissions climbing from 2,130 in 2016 to 3,200 by 2021.

Alcohol-related admissions account for less than 1% of all unplanned cancer hospitalisations. Researchers are less concerned with the proportion, however, and far more alarmed by the direction of travel.

“This is an alarming upward trend,” said Dr Anna Mehlich, an internist at John H. Stroger Jr. Hospital of Cook County, who presented the findings. “It may not sound very striking, but what was interesting was the constant upgrowing trend.”

Alcohol withdrawal drove 69.4% of these admissions. Intoxication accounted for a further 22.2%. For many patients, problematic drinking had progressed well beyond occasional excess.

A Well-Established but Underestimated Link

The relationship between alcohol and cancer is not new territory. Researchers have long established causal links between drinking and a range of malignancies, including breast, colorectal, oesophageal, head and neck, and liver cancers.

Some figures are stark. Alcohol use accounts for 3% of the 18.7 million cancer cases recorded worldwide each year. Heavy drinking nearly doubles the risk of colorectal cancer. Around 5,000 breast cancer cases in the US alone each year are attributable to just one alcoholic drink per day. Deaths linked to alcohol rose approximately 50% between 1990 and 2021.

Despite this, how alcohol use in cancer patients affects their treatment and recovery remains poorly understood. Dr Mehlich works primarily with patients from disadvantaged socioeconomic backgrounds. She observed this gap firsthand.

“The link between alcohol consumption and cancer is strong, but what is still missing in that story is how alcohol impacts the clinical course and outcomes of patients in oncology care,” she said. “My impression was that both can be very strongly related, and that drinking a significant amount of alcohol impacts oncology care.”

Who Faces the Highest Risk of Alcohol-Related Hospitalisations in Oncology?

Researchers drew on the National Inpatient Sample database and identified several notable risk factors.

Men were more than three times as likely as women to be admitted for alcohol-related reasons (OR = 3.18). Younger adults carried significantly higher odds compared with those aged 70 and over. The 30 to 49 age group showed nearly six times the risk (OR = 5.96).

Patients in rural communities were 29% more likely to be hospitalised than those in urban areas. Housing insecurity raised the odds by nearly six times (OR = 5.84). Depressive disorder more than tripled the likelihood (OR = 3.51). Opioid use disorder more than doubled it (OR = 2.37).

Dr Mehlich was not surprised by the risk factors themselves. Many mirror those researchers see in the general population. What caught her attention was the magnitude.

“The majority of these factors were also previously identified as independent risk factors in the general population,” she said. “But the magnitude surprised me.”

What Clinicians Can Do Right Now to Support At-Risk Patients

These findings carry clear practical implications for clinical teams. Alcohol-related hospitalisations in oncology often connect to fragmented care, poor follow-up, and compounding health complications such as liver disease. Each of these can undermine cancer treatment and worsen outcomes.

Dr Mehlich calls for earlier, more consistent screening. The ask is straightforward. Clinicians should ask patients whether they drink. If the answer is yes, they should find out how much. If a problem exists, they should address it.

“These patients can be lost to follow-up. They can have fragmented care. Their outcomes can be suboptimal because they can have multiple issues, such as cirrhosis,” she said. “Screen them sooner. We have the risk factors. If a patient doesn’t have a house or a place to go, if they have an underlying psychiatric disorder, this should raise an alarm in your head.”

Researchers acknowledge the study’s retrospective nature as a limitation. Future work will need to assess whether alcohol-related hospitalisations in oncology directly worsen patient outcomes over time.

The trend is moving in the wrong direction. The healthcare system, however, already has the tools and knowledge to intervene.

Source: dbrecoveryresources